Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
Superinvestors holding CLLS, Q2 2026
No superinvestor reported holding CLLS in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CLLS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2022
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−22.2%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−18.8%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−9.0%)